Global Reproductive Health Devices Market to Reach $3.7B by 2030

The worldwide reproductive health devices market is fertile ground for growth over the next seven years.

GlobalData estimates the sector to post $3.7 billion in sales in 2030, as more women’s health-related medical conditions are detected, treated, and promptly cured.
 
“Depending on the indication, female patients may opt for a combination of lifestyle changes, medications or undergo surgeries to treat their underlying sexual or reproductive health conditions,” GlobalData Senior Analyst Brian Hicks said.
 
Some common surgical procedures many women encounter in their lifetime to address their reproductive health concerns include hysteroscopy, laparoscopy, in-vitro fertilization (IVF), endometrial ablation, sterilization, and reversible contraceptive device insertions. Each of these utilize a variety of medical devices, such as hysteroscopes, laparoscopes, IVF catheters and media, tubal clips and rings, intrauterine devices (IUDs), hormonal implants, and diaphragms.
 
“Some key drivers of the growth of the reproductive health devices market include more women seeking medical attention for their sexual and reproductive health, technological advancements that enable improved diagnostic accuracies, and a greater number of treatment options being made available more than ever before,” Hicks stated.
 
While many of the reproductive health devices markets have been well established, there are still nearly 100 different products under development globally, the majority of which are in clinical stages of development and are reversible contraceptive devices. 
 
“As both copper IUD and hormonal implants markets are forecast to grow globally in particular due to rising preference towards such devices over alternative options, reversible contraceptive device manufacturers are taking note and investing more into their R&D and product development to meet the rising demand,” Hicks said.